Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Bridging the gap in Parkinson's disease research: from general pathophysiology to advanced 3d cell culture models

Keles B., Rumman B., Samarie MAJA., Gürsoy Özdemir Y., Öztop Cakmak Ö., Akyoldas G.

Narrative Review on Neuroinflammation, published in Cell Commun Signal (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Cell Commun Signal (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41382222
PMCID
PMC12696913
DOI
10.1186/s12964-025-02461-z
Citations
1

Abstract (original English)

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, having a substantial negative impact on the quality of life of patients with its wide range of motor and non-motor symptoms. PD has a complex etiology involving aging, genetic, and environmental factors. The hallmark of the pathology in PD is the accumulation of misfolded α-synuclein, a presynaptic vesicle-associated protein, in dopaminergic neurons, causing neuronal death in the substantia nigra pars compacta (SNpc) and other brain regions. This review focuses on the main pathophysiological mechanisms of PD and in vitro cell culture models. Conventional 2-dimensional (2D) systems can not properly mimic living tissue and reflect disease pathology. On the other hand, 3-dimensional (3D) cell culture models bring an innovative perspective to PD research because they offer tissue-like 3D environments that support the functioning and viability of cells. The potential use of spheroids and organoid systems, 3D bio-printing, microfluidic systems, and organ-on-chip models is discussed in comparison with traditional approaches using 2D. These methods have great potential for more realistic simulation of the dynamics of the disease, allowing the investigation of therapeutic molecules and targets. This review synthesizes current knowledge on PD mechanisms and 3D in vitro models, and explains why 3D offers advant

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansParkinson DiseaseModels, BiologicalCell Culture Techniques, Three Dimensional

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research